Oncology Central

News round-up: 11th European Breast Cancer Conference

0
Find out all the latest headlines from the 11th European Breast Cancer Conference taking place in Barcelona, Spain (21–23rd March).
  • Risk of a second breast cancer can be better quantified in women carrying a BRCA mutation
  • Women with DCIS at lowest risk of recurrence if post-menopausal or have estrogen receptor positive cancer
  • Screening helped reduce the average size of breast tumors decreased but size is now increasing again

Risk of a second breast cancer can be better quantified in women carrying a BRCA mutation

The risk of a second breast cancer in patients with high-risk BRCA gene mutations can be more precisely predicted by testing for several other genetic variants, each of which are known to have a small impact on breast cancer risk.

To view restricted content, please:
Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.